FDA increasingly halting human trials as companies pursue risky, cutting-edge drugs

wsj

6 min read . Updated: 10 Jan 2023, 06:23 PM IST Liz Essley Whyte, The Wall Street Journal

FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo (REUTERS) — FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo (REUTERS)

Agency places more holds on trials to protect patients, ensure studies are designed properly, Wall Street Journal review finds

The Food and Drug Administration is pressing pause on drug-company testing of experimental medicines more often, a side effect of the industry’s move into promising but less-proven technologies.